Mar 19 |
Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
Mar 11 |
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
|
Mar 7 |
Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia
|
Mar 6 |
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
|
Mar 6 |
Zacks.com featured highlights Modine Manufacturing, Indivior and Interface
|
Mar 5 |
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
|
Mar 4 |
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
|
Feb 29 |
Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
|
Feb 29 |
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
|
Feb 25 |
Earnings Update: Indivior PLC (LON:INDV) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
|